Sfoglia per Rivista HEART RHYTHM
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy
2019-01-01 Towbin, J. A.; Mckenna, W. J.; Abrams, D. J.; Ackerman, M. J.; Calkins, H.; Darrieux, F. C. C.; Daubert, J. P.; de Chillou, C.; Depasquale, E. C.; Desai, M. Y.; Estes, N. A. M.; Hua, W.; Indik, J. H.; Ingles, J.; James, C. A.; John, R. M.; Judge, D. P.; Keegan, R.; Krahn, A. D.; Link, M. S.; Marcus, F. I.; Mcleod, C. J.; Mestroni, L.; Priori, S. G.; Saffitz, J. E.; Sanatani, S.; Shimizu, W.; van Tintelen, J. P.; Wilde, A. A. M.; Zareba, W.
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary
2019-01-01 Towbin, J. A.; Mckenna, W. J.; Abrams, D. J.; Ackerman, M. J.; Calkins, H.; Darrieux, F. C. C.; Daubert, J. P.; de Chillou, C.; Depasquale, E. C.; Desai, M. Y.; Estes, N. A. M.; Hua, W.; Indik, J. H.; Ingles, J.; James, C. A.; John, R. M.; Judge, D. P.; Keegan, R.; Krahn, A. D.; Link, M. S.; Marcus, F. I.; Mcleod, C. J.; Mestroni, L.; Priori, S. G.; Saffitz, J. E.; Sanatani, S.; Shimizu, W.; van Tintelen, J. P.; Wilde, A. A. M.; Zareba, W.
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria.
2014-01-01 Savastano, S.; Rordorf, R.; Vicentini, A.; Petracci, B.; Taravelli, E.; Castelletti, S.; D'Errico, A.; Torchio, M.; Dossena, C.; Novara, P.; Dagradi, F.; Landolina, M.; Spazzolini, C.; Crotti, Lia; Schwartz, P. J.
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome.
2009-01-01 Crotti, Lia; Lewandowska, Ma; Schwartz, Peter; Insolia, Roberto; Pedrazzini, M; Bussani, E; Dagradi, F; George AL, Jr; Pagani, F.
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents.
2012-01-01 Hu, D.; Barajas Martínez, H.; Medeiros Domingo, A.; Crotti, Lia; Veltmann, C.; Schimpf, R.; Urrutia, J.; Alday, A.; Casis, O.; Pfeiffer, R.; Burashnikov, E.; Caceres, G.; Tester, D. J.; Wolpert, C.; Borggrefe, M.; Schwartz, Peter; Ackerman, M. J.; Antzelevitch, C.
All LQT3 patients need an ICD. True or false?
2009-01-01 Schwartz, Peter; Spazzolini, C; Crotti, Lia
Atrial arrhythmias prevalence in heart transplant patients.
2005-01-01 Landolina, M.; Petracci, B.; DE FERRARI, Gaetano; Frattini, F.; Pellegrini, Carlo; Vigano', Mario; Rordorf, R.; Pentimalli, F.; Vicentini, A.
Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?
2016-01-01 Ackerman, Mj; Priori, SILVIA GIULIANA; Dubin, Am; Kowey, P; Linker, Nj; Slotwiner, D; Triedman, J; Van Hare, Gf; Gold, M. r. 9.
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome.
2007-01-01 Schwartz, Peter; Crotti, Lia
Catecholaminergic polymorphic ventricular tachycardia
2005-01-01 Francis, J; Sankar, V; Krishnan Nair, V; Priori, SILVIA GIULIANA
Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation
2009-01-01 Cerrone, M; Napolitano, C; Priori, SILVIA GIULIANA
Cutting nerves and saving lives.
2009-01-01 Schwartz, Peter
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.
2007-01-01 Napolitano, C; Priori, SILVIA GIULIANA
Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome
2004-01-01 Shimizu, W; Noda, T; Takaki, H; Nagaya, N; Satomi, K; Kurita, T; Suyama, K; Aihara, N; Sunagawa, K; Echigo, S; Miyamoto, Y; Yoshimasa, Y; Nakamura, K; Ohe, T; Towbin, Ja; Priori, SILVIA GIULIANA; Kamakura, S.
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website(www.brugadadrugs.org)
2009-01-01 Postema, Pg; Wolpert, C; Amin, As; Probst, V; Borggrefe, M; Roden, Dm; Priori, SILVIA GIULIANA; Tan, Hl; Hiraoka, M; Brugada, J; Wilde, A. A.
Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications
2010-01-01 Schwartz, Peter
Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications.
2010-01-01 Schwartz, Peter
Elevated plasma levels of tumor necrosis factor alpha are associated with poor left ventricular reverse remodelling after cardiac resynchronization therapy.
2008-01-01 Rordorf, R; Landolina, M; Sanzo, A; Savastano, S; De Amici, M; Vicentini, A; Belvito, C; Petracci, B; Schwartz, Peter
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome
2019-01-01 Milman, A.; Andorin, A.; Postema, P. G.; Gourraud, J. -B.; Sacher, F.; Mabo, P.; Kim, S. -H.; Maeda, S.; Takahashi, Y.; Kamakura, T.; Aiba, T.; Conte, G.; Juang, J. J. M.; Leshem, E.; Michowitz, Y.; Fogelman, R.; Hochstadt, A.; Mizusawa, Y.; Giustetto, C.; Arbelo, E.; Huang, Z.; Corrado, D.; Delise, P.; Allocca, G.; Takagi, M.; Wijeyeratne, Y. D.; Mazzanti, A.; Brugada, R.; Casado-Arroyo, R.; Champagne, J.; Calo, L.; Sarquella-Brugada, G.; Jespersen, C. H.; Tfelt-Hansen, J.; Veltmann, C.; Priori, S. G.; Behr, E. R.; Yan, G. -X.; Brugada, J.; Gaita, F.; Wilde, A. A. M.; Brugada, P.; Kusano, K. F.; Hirao, K.; Nam, G. -B.; Probst, V.; Belhassen, B.
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes.
2013-01-01 Priori, SILVIA GIULIANA; Wilde, Aa; Horie, M; Cho, Y; Behr, Er; Berul, C; Blom, N; Brugada, J; Chiang, Ce; Huikuri, H; Kannankeril, P; Krahn, A; Leenhardt, A; Moss, A; Schwartz, Peter; Shimizu, W; Tomaselli, G; Tracy, C.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy | 1-gen-2019 | Towbin, J. A.; Mckenna, W. J.; Abrams, D. J.; Ackerman, M. J.; Calkins, H.; Darrieux, F. C. C.; Daubert, J. P.; de Chillou, C.; Depasquale, E. C.; Desai, M. Y.; Estes, N. A. M.; Hua, W.; Indik, J. H.; Ingles, J.; James, C. A.; John, R. M.; Judge, D. P.; Keegan, R.; Krahn, A. D.; Link, M. S.; Marcus, F. I.; Mcleod, C. J.; Mestroni, L.; Priori, S. G.; Saffitz, J. E.; Sanatani, S.; Shimizu, W.; van Tintelen, J. P.; Wilde, A. A. M.; Zareba, W. | |
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary | 1-gen-2019 | Towbin, J. A.; Mckenna, W. J.; Abrams, D. J.; Ackerman, M. J.; Calkins, H.; Darrieux, F. C. C.; Daubert, J. P.; de Chillou, C.; Depasquale, E. C.; Desai, M. Y.; Estes, N. A. M.; Hua, W.; Indik, J. H.; Ingles, J.; James, C. A.; John, R. M.; Judge, D. P.; Keegan, R.; Krahn, A. D.; Link, M. S.; Marcus, F. I.; Mcleod, C. J.; Mestroni, L.; Priori, S. G.; Saffitz, J. E.; Sanatani, S.; Shimizu, W.; van Tintelen, J. P.; Wilde, A. A. M.; Zareba, W. | |
A comprehensive electrocardiographic, molecular, and echocardiographic study of Brugada syndrome: validation of the 2013 diagnostic criteria. | 1-gen-2014 | Savastano, S.; Rordorf, R.; Vicentini, A.; Petracci, B.; Taravelli, E.; Castelletti, S.; D'Errico, A.; Torchio, M.; Dossena, C.; Novara, P.; Dagradi, F.; Landolina, M.; Spazzolini, C.; Crotti, Lia; Schwartz, P. J. | |
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. | 1-gen-2009 | Crotti, Lia; Lewandowska, Ma; Schwartz, Peter; Insolia, Roberto; Pedrazzini, M; Bussani, E; Dagradi, F; George AL, Jr; Pagani, F. | |
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents. | 1-gen-2012 | Hu, D.; Barajas Martínez, H.; Medeiros Domingo, A.; Crotti, Lia; Veltmann, C.; Schimpf, R.; Urrutia, J.; Alday, A.; Casis, O.; Pfeiffer, R.; Burashnikov, E.; Caceres, G.; Tester, D. J.; Wolpert, C.; Borggrefe, M.; Schwartz, Peter; Ackerman, M. J.; Antzelevitch, C. | |
All LQT3 patients need an ICD. True or false? | 1-gen-2009 | Schwartz, Peter; Spazzolini, C; Crotti, Lia | |
Atrial arrhythmias prevalence in heart transplant patients. | 1-gen-2005 | Landolina, M.; Petracci, B.; DE FERRARI, Gaetano; Frattini, F.; Pellegrini, Carlo; Vigano', Mario; Rordorf, R.; Pentimalli, F.; Vicentini, A. | |
Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent? | 1-gen-2016 | Ackerman, Mj; Priori, SILVIA GIULIANA; Dubin, Am; Kowey, P; Linker, Nj; Slotwiner, D; Triedman, J; Van Hare, Gf; Gold, M. r. 9. | |
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome. | 1-gen-2007 | Schwartz, Peter; Crotti, Lia | |
Catecholaminergic polymorphic ventricular tachycardia | 1-gen-2005 | Francis, J; Sankar, V; Krishnan Nair, V; Priori, SILVIA GIULIANA | |
Catecholaminergic polymorphic ventricular tachycardia: A paradigm to understand mechanisms of arrhythmias associated to impaired Ca(2+) regulation | 1-gen-2009 | Cerrone, M; Napolitano, C; Priori, SILVIA GIULIANA | |
Cutting nerves and saving lives. | 1-gen-2009 | Schwartz, Peter | |
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. | 1-gen-2007 | Napolitano, C; Priori, SILVIA GIULIANA | |
Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome | 1-gen-2004 | Shimizu, W; Noda, T; Takaki, H; Nagaya, N; Satomi, K; Kurita, T; Suyama, K; Aihara, N; Sunagawa, K; Echigo, S; Miyamoto, Y; Yoshimasa, Y; Nakamura, K; Ohe, T; Towbin, Ja; Priori, SILVIA GIULIANA; Kamakura, S. | |
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website(www.brugadadrugs.org) | 1-gen-2009 | Postema, Pg; Wolpert, C; Amin, As; Probst, V; Borggrefe, M; Roden, Dm; Priori, SILVIA GIULIANA; Tan, Hl; Hiraoka, M; Brugada, J; Wilde, A. A. | |
Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications | 1-gen-2010 | Schwartz, Peter | |
Efficacy of left cardiac sympathetic denervation has an unforeseen side effect: medicolegal complications. | 1-gen-2010 | Schwartz, Peter | |
Elevated plasma levels of tumor necrosis factor alpha are associated with poor left ventricular reverse remodelling after cardiac resynchronization therapy. | 1-gen-2008 | Rordorf, R; Landolina, M; Sanzo, A; Savastano, S; De Amici, M; Vicentini, A; Belvito, C; Petracci, B; Schwartz, Peter | |
Ethnic differences in patients with Brugada syndrome and arrhythmic events: New insights from Survey on Arrhythmic Events in Brugada Syndrome | 1-gen-2019 | Milman, A.; Andorin, A.; Postema, P. G.; Gourraud, J. -B.; Sacher, F.; Mabo, P.; Kim, S. -H.; Maeda, S.; Takahashi, Y.; Kamakura, T.; Aiba, T.; Conte, G.; Juang, J. J. M.; Leshem, E.; Michowitz, Y.; Fogelman, R.; Hochstadt, A.; Mizusawa, Y.; Giustetto, C.; Arbelo, E.; Huang, Z.; Corrado, D.; Delise, P.; Allocca, G.; Takagi, M.; Wijeyeratne, Y. D.; Mazzanti, A.; Brugada, R.; Casado-Arroyo, R.; Champagne, J.; Calo, L.; Sarquella-Brugada, G.; Jespersen, C. H.; Tfelt-Hansen, J.; Veltmann, C.; Priori, S. G.; Behr, E. R.; Yan, G. -X.; Brugada, J.; Gaita, F.; Wilde, A. A. M.; Brugada, P.; Kusano, K. F.; Hirao, K.; Nam, G. -B.; Probst, V.; Belhassen, B. | |
Executive summary: HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes. | 1-gen-2013 | Priori, SILVIA GIULIANA; Wilde, Aa; Horie, M; Cho, Y; Behr, Er; Berul, C; Blom, N; Brugada, J; Chiang, Ce; Huikuri, H; Kannankeril, P; Krahn, A; Leenhardt, A; Moss, A; Schwartz, Peter; Shimizu, W; Tomaselli, G; Tracy, C. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile